Niva Bupa Health Insurance Company Ltd

As of November 28, 2025, Niva Bupa Health's technical stance is bearish due to negative indicators like a bearish MACD and moving averages, despite a mildly bullish signal from Dow Theory.

Niva Bupa Health's latest Q2 FY26 results show a net loss of ₹35.27 crores despite a 17.21% increase in premium income, indicating growth in customer base but ongoing profitability challenges. The company needs to reassess its operational strategies to convert this growth into sustainable profits.

Niva Bupa Health experienced significant growth from March 2024 to March 2025, with net sales rising to 4,894.46 Cr and profit after tax increasing to 213.52 Cr, while total assets grew to 9,760.16 Cr. The company improved its operating profit margin to 1.19% and enhanced cash flow from operating activities to 1,654.00 Cr.

The next results date for Niva Bupa Health is November 3, 2025.

As of 17-Oct, Niva Bupa Health Insurance Company's stock price is Rs 75.96, down 2.89%, and has underperformed its sector. Despite strong long-term fundamentals, recent declines in profits and investor interest have negatively impacted its performance.

As of 25-Sep, Niva Bupa Health Insurance Company's stock price is at 80.95, down 0.26%, and has underperformed recently, trading below key moving averages. Despite a rise in investor participation and outperforming its sector today, the company faces concerns over disappointing quarterly results and an expensive valuation.

Niva Bupa Health Insurance Company Ltd has seen significant trading activity, with nearly 27 million shares exchanged. The stock opened at Rs 90.00 and closed at Rs 82.01, underperforming its sector. Despite fluctuations, it maintains a market capitalization of Rs 15,485.52 crores, indicating stable liquidity.

Niva Bupa Health Insurance Company Ltd has seen significant trading activity, with a volume of over 26.9 million shares and a market capitalization of Rs 15,710.70 crores. The stock's performance indicates strong investor engagement and liquidity, outperforming its sector and demonstrating a positive trend across various moving averages.

Niva Bupa Health Insurance Company Ltd has become one of the most actively traded stocks today, with over 10.5 million shares exchanged. The stock has shown strong performance, trading above key moving averages and experiencing increased investor participation, highlighting its significant liquidity in the insurance sector.

Niva Bupa Health's latest results are concerning, showing a significant decline in profitability with a net loss of Rs -91.44 crore and a drop in earnings per share to Rs -0.50, despite a year-on-year revenue growth of 24.68%. The company faces challenges with a decrease in net sales growth and operating profit margins.

As of 31-Jul, Niva Bupa Health Insurance Company Ltd's stock price is rising to Rs 87.57, reflecting a 2.88% increase. The stock has shown strong performance, outperforming its sector and indicating positive momentum, despite some concerns regarding recent flat results and high valuation metrics.

Niva Bupa Health has shown significant financial growth, with net sales increasing to 4,894.46 Cr in March 2025 from 3,811.25 Cr in March 2024, and a notable rise in profit after tax to 213.52 Cr from 81.85 Cr, reflecting strong operational performance. Total assets also grew to 6,191.87 Cr, indicating a positive trend across various financial metrics.